Reversal effect on norepinephrine induced lipolysis in isolated perfused rat liver by a beta blocking agent H 56-28 (Alloprenalol).
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000526:Alprenolol / Q000494:pharmacology; D000818:Animals; D001769:Blood; D004357:Drug Synergism; D005230:Fatty Acids, Nonesterified / Q000096:biosynthesis*; D066298:In Vitro Techniques; D007700:Kinetics; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects*; D008055:Lipids / Q000097:blood / Q000494:pharmacology; D008099:Liver / Q000187:drug effects*; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D010477:Perfusion; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D013565:Sympatholytics; D000526:Alprenolol; D009638:Norepinephrine